These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35975953)

  • 1. Immune mechanisms induced by sublingual immunotherapy in allergic respiratory diseases.
    Gazi U; Bahceciler NN
    Clin Exp Immunol; 2022 Sep; 209(3):262-269. PubMed ID: 35975953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
    Hesse L; Petersen AH; Nawijn MC
    Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.
    Suárez-Fueyo A; Ramos T; Galán A; Jimeno L; Wurtzen PA; Marin A; de Frutos C; Blanco C; Carrera AC; Barber D; Varona R
    J Allergy Clin Immunol; 2014 Jan; 133(1):130-8.e1-2. PubMed ID: 24290282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of IgG
    Heeringa JJ; McKenzie CI; Varese N; Hew M; Bakx ATCM; Aui PM; Rolland JM; O'Hehir RE; van Zelm MC
    Allergy; 2020 May; 75(5):1121-1132. PubMed ID: 31587307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune mechanisms of sublingual immunotherapy.
    Jay DC; Nadeau KC
    Curr Allergy Asthma Rep; 2014 Nov; 14(11):473. PubMed ID: 25195100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma.
    Hesse L; Brouwer U; Petersen AH; Gras R; Bosman L; Brimnes J; Oude Elberink JNG; van Oosterhout AJM; Nawijn MC
    Clin Exp Allergy; 2018 Aug; 48(8):1035-1049. PubMed ID: 29752757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells.
    Scadding GW; Shamji MH; Jacobson MR; Lee DI; Wilson D; Lima MT; Pitkin L; Pilette C; Nouri-Aria K; Durham SR
    Clin Exp Allergy; 2010 Apr; 40(4):598-606. PubMed ID: 20184605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
    Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic children.
    Kim EH; Keet CA; Virkud YV; Chin S; Ye P; Penumarti A; Smeekens J; Guo R; Yue X; Li Q; Kosorok MR; Kulis MD; Burks AW
    J Allergy Clin Immunol; 2023 Jun; 151(6):1558-1565.e6. PubMed ID: 36828080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of allergen immunotherapy.
    Şahin E; Bafaqeeh SA; Güven SG; Çetinkaya EA; Muluk NB; Coşkun ZO; Lopatin A; Kar M; Pinarbasli MO; Cingi C
    Am J Rhinol Allergy; 2016 Sep; 30(5):1-3. PubMed ID: 27658024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse immune mechanisms of allergen immunotherapy for allergic rhinitis with and without asthma.
    Shamji MH; Sharif H; Layhadi JA; Zhu R; Kishore U; Renz H
    J Allergy Clin Immunol; 2022 Mar; 149(3):791-801. PubMed ID: 35093483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of IL-35 in sublingual allergen immunotherapy.
    Shamji MH; Layhadi JA; Achkova D; Kouser L; Perera-Webb A; Couto-Francisco NC; Parkin RV; Matsuoka T; Scadding G; Ashton-Rickardt PG; Durham SR
    J Allergy Clin Immunol; 2019 Mar; 143(3):1131-1142.e4. PubMed ID: 30053528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
    Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
    Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shorter dosing intervals of sublingual immunotherapy lead to more efficacious treatment in a mouse model of allergic inflammation.
    Rask C; Brimnes J; Lund K
    Scand J Immunol; 2010 Jun; 71(6):403-12. PubMed ID: 20500692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
    Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual immunotherapy: an update on immunologic and functional effects.
    Ciprandi G; Fenoglio D; Cirillo I; Tosca MA; La Rosa M; Licari A; Marseglia A; Barberi S; Marseglia GL
    Allergy Asthma Proc; 2007; 28(1):40-3. PubMed ID: 17390756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms underlying the induction of regulatory T cells by sublingual immunotherapy.
    Tanaka Y; Fukumoto S; Sugawara S
    J Oral Biosci; 2019 Jun; 61(2):73-77. PubMed ID: 31109864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy.
    Baron-Bodo V; Horiot S; Lautrette A; Chabre H; Drucbert AS; Danzé PM; Sénéchal H; Peltre G; Galvain S; Zeldin RK; Horak F; Moingeon P
    Clin Exp Allergy; 2013 Dec; 43(12):1362-73. PubMed ID: 24261946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinated IgG2 and IgE responses as a marker of allergen immunotherapy efficacy.
    Bordas-Le Floch V; Berjont N; Batard T; Varese N; O'Hehir RE; Canonica WG; van Zelm MC; Mascarell L
    Allergy; 2022 Apr; 77(4):1263-1273. PubMed ID: 34551124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.